Bleeding Phenotypes in Inherited Platelet Function Disorders: Insights From the ATHNdataset
Most platelet disorder patients remain diagnostically unclassified and suffer serious bleeds, identifying a major gap in rare disease care.
Analysis of 2302 IPFD patients in the national ATHNdataset revealed substantial morbidity (intracranial hemorrhage, joint bleeds) across all subtypes, with 81.6% of patients carrying an unclassified 'IPFD-other' designation indicating significant diagnostic underspecification. These real-world data establish baseline bleeding burden for IPFDs and highlight the diagnostic gap requiring attention, particularly for rarer platelet disorders beyond Glanzmann thrombasthenia and Bernard-Soulier syndrome.
What the study was
- Study design
- Retrospective cohort study; national registry (ATHNdataset)
- Population
- 2302 individuals with inherited platelet function disorders (IPFDs) in US national registry
- Sample size
- 2302
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- J Pediatr Hematol Oncol
Why it surfaced
Large national registry study (n=2302) characterizing morbidity burden in rare platelet disorders, revealing 81.6% diagnostic gap (IPFD-other). Clinically important for rare hematology disease recognition.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.